MarketWatch recently had a news-release on “Markets and Outsourcing for Clinical Activities.” In the article, it’s noted that while in the US and Europe costs are continuing to rise for clinical activities, sales are not growing- or growing at an insignificant rate. This is in stark contrast to emerging markets, where the opposite seems to hold true. Not surprisingly,  this leads to  more medical device organizations evaluating an expansion of their clinical programs into emerging markets to cut costs and boost sales.